Premium
Disease status in chronic inflammatory demyelinating polyneuropathy: inter‐centre comparative analysis and correlates
Author(s) -
Rajabally Y. A.,
Cassereau J.,
Robbe A.,
Nicolas G.
Publication year - 2015
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.12767
Subject(s) - chronic inflammatory demyelinating polyneuropathy , medicine , cohort , disease , electrophysiology , compound muscle action potential , immunology , antibody
Background and Purpose Chronic inflammatory demyelinating polyneuropathy ( CIDP ) may have variable evolution profiles, which have not been compared between cohorts. The relationship of disease status with motor strength, function and electrophysiology is uncertain. Methods Disease status was studied with a simplified proposed scale in two patient cohorts totalling 72 subjects from Leicester, UK , and Angers, France. Clinical and electrophysiological records were analysed. Results Independent ascertainment of disease status in each cohort revealed similar rates of remission ( P = 0.23), stable/improving disease ( P = 0.34) and unstable/active disease ( P = 1). No correlation was ascertained with strength or function. Median nerve compound muscle action potential was the only independent electrophysiological predictor of disease status ascertained ( P = 0.046). Conclusions Disease status distribution may represent an important comparative indicator for management of CIDP cohorts and could be useful for benchmarking service and treatment provision. Degree of upper limb motor axonal loss may represent a useful electrophysiological marker of disease status in CIDP .